Want to see AYTU full AI Analyst Report?
Total Valuation
Aytu BioScience has a market cap or net worth of $23.91M. The enterprise value is $33.34.
Market Cap$23.91M
Enterprise Value$33.34
Share Statistics
Aytu BioScience has 10,866,708 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding10,866,708
Owned by Insiders5.14%
Owned by Institutions65.51%
Financial Efficiency
Aytu BioScience’s return on equity (ROE) is -0.40 and return on invested capital (ROIC) is -14.19%.
Return on Equity (ROE)-0.40
Return on Assets (ROA)-0.14
Return on Invested Capital (ROIC)-14.19%
Return on Capital Employed (ROCE)-0.17
Revenue Per Employee757.50K
Profits Per Employee-187.53K
Employee Count76
Asset Turnover0.55
Inventory Turnover3.03
Valuation Ratios
The current PE Ratio of Aytu BioScience is ―. Aytu BioScience’s PEG ratio is 0.04.
PE Ratio―
PS Ratio0.46
PB Ratio0.75
Price to Fair Value0.75
Price to FCF8.14
Price to Operating Cash Flow8.23
PEG Ratio0.04
Income Statement
In the last 12 months, Aytu BioScience had revenue of 57.57M and earned -14.25M in profits. Earnings per share was -1.16.
Revenue57.57M
Gross Profit36.82M
Operating Income-8.31M
Pretax Income-14.23M
Net Income-14.25M
EBITDA-4.38M
Earnings Per Share (EPS)-1.16
Cash Flow
In the last 12 months, operating cash flow was 3.28M and capital expenditures -29.00K, giving a free cash flow of 3.25M billion.
Operating Cash Flow3.28M
Free Cash Flow3.25M
Free Cash Flow per Share0.30
Dividends & Yields
Aytu BioScience pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.75
52-Week Price Change17.02%
50-Day Moving Average2.22
200-Day Moving Average2.38
Relative Strength Index (RSI)50.87
Average Volume (3m)41.16K
Important Dates
Aytu BioScience upcoming earnings date is Nov 16, 2026, TBA (Confirmed).
Last Earnings DateSep 22, 2026
Next Earnings DateNov 16, 2026
Ex-Dividend Date―
Financial Position
Aytu BioScience as a current ratio of 1.13, with Debt / Equity ratio of 51.33%
Current Ratio1.13
Quick Ratio1.00
Debt to Market Cap0.65
Net Debt to EBITDA1.87
Interest Coverage Ratio4.39
Taxes
In the past 12 months, Aytu BioScience has paid -21.00K in taxes.
Income Tax-21.00K
Effective Tax Rate<0.01
Enterprise Valuation
Aytu BioScience EV to EBITDA ratio is -4.17, with an EV/FCF ratio of 5.62.
EV to Sales0.32
EV to EBITDA-4.17
EV to Free Cash Flow5.62
EV to Operating Cash Flow5.57
Balance Sheet
Aytu BioScience has $26.31M in cash and marketable securities with $18.11M in debt, giving a net cash position of $8.20M billion.
Cash & Marketable Securities$26.31M
Total Debt$18.11M
Net Cash$8.20M
Net Cash Per Share$0.75
Tangible Book Value Per Share-$0.50
Margins
Gross margin is 63.95%, with operating margin of -14.44%, and net profit margin of -24.76%.
Gross Margin63.95%
Operating Margin-14.44%
Pretax Margin-24.72%
Net Profit Margin-24.76%
EBITDA Margin-7.62%
EBIT Margin-21.43%
Analyst Forecast
The average price target for Aytu BioScience is $7.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$7.00
Price Target Upside204.35% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast-13.27%
EPS Growth Forecast27.11%